Truist Securities Maintains Hold on Agilon Health, Raises Price Target to $6.5
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has maintained a Hold rating on Agilon Health (NYSE:AGL) and raised the price target from $6.4 to $6.5.

May 24, 2024 | 12:29 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Truist Securities has maintained a Hold rating on Agilon Health and raised the price target from $6.4 to $6.5.
The Hold rating suggests a neutral stance, indicating that the stock is expected to perform in line with the market. The slight increase in the price target from $6.4 to $6.5 shows a marginally positive outlook but not enough to change the overall rating.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100